Kerstin Becker

12PUBLICATIONS
133CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Molecular targetsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.

Linus Wahnschaffe, Dennis Jungherz, Tony A Müller

|Feb 19, 2026
Composite SMG5-SMG6 PIN domain formation is essential for NMD.

Katharina Kurscheidt, Sophie Theunissen, Natalia Pasquali

|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Jan-Michel Heger, Julia Mattlener, Helen Kaul

|Sep 02, 2025
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Apr 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Annika Dechow, Sanna Timonen, Aleksandr Ianevski

|Apr 10, 2025
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

Eric Hahnen, Jan Hauke, Karen Gelmon

Pageof 2

Frequent Collaborators

3 joint publications

Michael J Hallek

2 joint publications

Jan-Michel Heger

2 joint publications

Julia Mattlener

2 joint publications

Jessica Schneider